ClinicalTrials.gg
Drug

Cysteamine clinical trials

Also written RP103, PROCYSBI® and Cystagon.

studies test it
26
open now
1
in phase 3
8
first study started
1998

How each study uses Cysteamine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Cysteamine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 Aug 1994 · CYSTAGON · NDA 020392 (FDA, Drugs@FDA)
European Union
23 Jun 1997 · Cystagon · EMEA/H/C/000125 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Cysteamine
10
Cysteamine Bitartrate
5
cysteamine bitartrate delayed-release capsules
2

Brand

PROCYSBI®
3
Cystagon
2

Development codes

RP103
7
NM001
1

Other names

Mercaptamine
1

Studies by the year they started

24 studies that test it; most in 2010 (3)

Studies that test Cysteamine, by start year
YearStudies
19981
19991
20011
20041
20082
20092
20103
20111
20121
20131
20142
20151
20162
20192
20201
20211
20251

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
10
Phase 3
8
Phase 4
1
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 16

Amgen (7) · National Eye Institute (NEI) (2) · Hasanuddin University (1) · Recordati Rare Diseases (1) · China Medical University Hospital (1) · Children's Hospital Medical Center, Cincinnati (1) · NovaBiotics Ltd. (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

Often tested with

Tested in the same studies.

Gamma-Aminobutyric Acid (1) · Deanol (1) · Bakuchiol (1) · Zidovudine (1) · Lopinavir-ritonavir drug combination (1) · Hydroxychloroquine (1) · Lopinavir (1) · Ritonavir (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Cysteamine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 26

See all 26 studies that test Cysteamine →

As the comparator · 1 — what is tested is compared with Cysteamine

Codes

What other systems call Cysteamine · ClinicalTrials.gg INT007287

  • MeSH (NLM) D003543CysteamineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 5UX2SD1KE2CYSTEAMINEConfirmed FDA, NLM, Wikidata
  • RxNorm 3022Confirmed FDA, Wikidata
  • Wikidata Q617563cysteamineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61696CysteamineOne source FDA
  • DrugBank DB00847One source Wikidata

Also registered as cysteamine bitartrate (UNII QO84GZ3TST · RxNorm 81990) and cysteamine hydrochloride (UNII IF1B771SVB · RxNorm 1426886).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.